Plasma-derived medicinal products: demand and clinical use

被引：14
|
作者：
Grazzini, Giuliano [1 ]
Mannucci, Pier Mannuccio [2 ]
Oleari, Fabrizio [3 ]
机构：
[1] Italian Natl Blood Ctr, Natl Inst Hlth, I-00162 Rome, Italy
[2] IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Sci Direct, Milan, Italy
[3] Natl Inst Hlth, Rome, Italy
来源：
BLOOD TRANSFUSION | 2013年 / 11卷
关键词：
ITALIAN DEMAND; POLYVALENT IMMUNOGLOBULINS; PROTHROMBIN COMPLEX; SELF-SUFFICIENCY; FACTOR-VIII; FACTOR-IX; FRACTIONATION; SYSTEM;
D O I：
10.2450/2013.002s
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S2 / S5
页数：4
相关论文
共 50 条
  • [31] Accessibility to plasma-derived medicinal products in Malaysia: The challenges faced by patients with inborn errors of immunity
    Lim, Bruce Wee Diong
    Abdul Latiff, Amir Hamzah
    ASIA PACIFIC ALLERGY, 2024, 14 (01) : 1 - 4
  • [32] UK donor plasma could have an immediate beneficial effect on the availability of plasma-derived medicinal products in Europe
    Thomas, Stephen
    Ahmed, Venus
    Roberts, Barnaby
    Wright, Peter
    Miflin, Gail
    VOX SANGUINIS, 2023, 118 (09) : 809 - 810
  • [33] Shortage of plasma-derived products: a looming crisis?
    Li Covington, Mischa
    Voma, Chesinta
    Stowell, Sean R.
    BLOOD, 2022, 139 (21) : 3222 - 3225
  • [34] Use and Future Investigations of Recombinant and Plasma-Derived Coagulation and Anticoagulant Products in the Neonate
    Punzalan, Rowena C.
    Gottschall, Jerome L.
    TRANSFUSION MEDICINE REVIEWS, 2016, 30 (04) : 189 - 196
  • [35] The increased demand for plasma-derived factor VIII in Italy
    Arcieri, Romano
    Calizzani, Gabriele
    Candura, Fabio
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2017, 15 (03) : 279 - 280
  • [36] Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease
    Josephson, CD
    Abshire, TC
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (01) : 35 - 49
  • [37] Verification of effective Zika virus reduction by production steps used in the manufacture of plasma-derived medicinal products
    Roth, Nathan J.
    Schaefer, Wolfram
    Popp, Birgit
    Stucki, Martin
    Fang, Randel
    TRANSFUSION, 2017, 57 (03) : 720 - 721
  • [38] Virus inactivation during the freeze-drying processes as used for the manufacture of plasma-derived medicinal products
    Unger, Ulrike
    Poelsler, Gerhard
    Modrof, Jens
    Kreil, Thomas R.
    TRANSFUSION, 2009, 49 (09) : 1924 - 1930
  • [39] Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products
    Skinner, Mark W.
    Hoppe, P. Ann Hedlund
    Grabowski, Henry G.
    Manning, Richard
    Tachdjian, Raffi
    Crone, James F.
    Youngner, Stuart J.
    TRANSFUSION, 2016, 56 (11) : 2889 - 2894
  • [40] Increasing unpaid plasma collection by blood establishments to ensure availability of plasma-derived medicinal products and blood components in Europe
    Tiberghien, P.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2021, 28 (04) : 331 - 333
12345